Join us for an insightful webinar on the cutting-edge innovations in oncology clinical trials. With over 50% of global trials focusing on oncology, this field is at the forefront of medical research, addressing a critical need for new and effective therapies. Our two expert speakers will delve into the latest advancements in clinical trial designs that not only aim to speed up NDA approvals but also ensure patient safety.
Discover how these innovations are shaping the future of oncology and bringing hope to millions worldwide. Don’t miss this opportunity to learn from leading experts in an area of significant medical interest.
🎙️ Speakers:
Dr. Giorgio Massimini – Consultant in Oncology Trials, GPM Biomedical Consulting
Yasser Mostafa Kamel, MD – Visiting Senior Lecturer, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King’s College London
📌 Register now to secure your spot: https://us02web.zoom.us/webinar/register/WN_aEztFYjqQCiZMhQkyuSXhA
🔍 About the Speakers:
Dr. Giorgio Massimini, a consultant in oncology trials at GPM Biomedical Consulting, has over 30 years of experience in clinical research and development. He joined Merck KGaA in 2010, where he advanced to Head of Early Clinical Development Oncology, contributing to the development of multiple oncology compounds. Prior to Merck, he worked at Roche, Pharmacia, and Novartis, leading projects that resulted in global drug approvals. He retired from Merck KGaA in 2021 as Vice President of External Innovation. Dr. Massimini holds a Medical Degree, post-doctoral degrees in Clinical Biology and Biochemistry, and is an active member of several professional societies with over 60 publications and eight patents.
Dr. Yasser Mostafa Kamel is a Visiting Senior Lecturer at King’s College London with over 25 years of experience in drug development, specializing in oncology and hematology. A UK-certified physician, he holds advanced degrees from prestigious institutions worldwide. Dr. Kamel has developed treatments for various cancers, served as a Clinical Fellow, and is involved in numerous expert groups and organizations such as ASCO and the Faculty of Pharmaceutical Medicine. He supervises graduate students and is a Fellow of the Royal Society of Medicine.
📝 Don’t forget to sign up for our Newsletter to receive future updates from GMDP Academy!
Join us for an enlightening discussion that promises to reshape your perspective on the future of clinical trials in oncology.
